CCM
Cutter Capital Management Portfolio holdings
AUM
$230M
1-Year Est. Return
11.53%
This Fund
S&P 500
1 Year Est. Return
+11.53%
AUM
$230M
AUM Growth
-$14.4M
(-5.9%)
Holding
31
Top Buys
| 1 | +$17.2M | |
| 2 | +$16.2M | |
| 3 | +$15M | |
| 4 |
Roivant Sciences
ROIV
|
+$14.1M |
| 5 |
VRNA
Verona Pharma
VRNA
|
+$9.57M |
Top Sells
| 1 | +$22.4M | |
| 2 | +$20.5M | |
| 3 | +$18.1M | |
| 4 |
Sarepta Therapeutics
SRPT
|
+$15.1M |
| 5 |
Royalty Pharma
RPRX
|
+$12.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moderna
MRNA
$22.8B
| – | – |
-197,500
|
|
||
27
Neumora Therapeutics
NMRA
$520M
| – | – |
-150,000
|
|
||
28
Regeneron Pharmaceuticals
REGN
$83.3B
| – | – |
-31,500
|
|
||
|
29
Sarepta Therapeutics
SRPT
$1.69B
| – | – |
-124,256
|
|
||
30
Vera Therapeutics
VERA
$2.81B
| – | – |
-212,696
|
|
||
31
Viridian Therapeutics
VRDN
$2.9B
| – | – |
-628,677
|
|